Abiopharma

- Femasys Regains Compliance with Nasdaq Listing Requirements

CROWN HOLDINGS SCHEDULES SECOND QUARTER 2026 EARNINGS CONFERENCE CALL

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

Lamb Weston to Announce Fourth Quarter and Full Fiscal Year 2026 Financial Results on July 24, 2026

Sensormatic Solutions Forecasts August as Peak U.S. Back-to-School Shopping Period

Femasys Regains Compliance with Nasdaq Listing Requirements

Regions Institutional Services Names Melissa Hancock as Corporate Trust Client Services Executive

8x8 Introduces AI Routing: Reimagined Intelligent Customer Routing, Built for the Entire Organization

Dasseti Launches Integration with Nasdaq eVestment™ Omni to Streamline Consultant Database Narrative Management

Native Launches Reformulated Moisturizing Body Wash Designed to Gently Cleanse and Hydrate Skin